Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek, shared on X, about an article that she and her collogues co-authored in Nature:
“Very proud and happy to share that our work on neoadjuvant IO in pMMR colon cancers has been published online in Nature after presentation at ESMO25.
Read on how genomic instability, P53mt and proliferation may aid in predicting responses.”
Title: Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.
Authors: Pedro B. Tan, Yara L. Verschoor, José G. van den Berg, Sara Balduzzi, Niels F. M. Kok, Marieke E. Ijsselsteijn, Kat Moore, Adham Jurdi, Antony Tin, Paulien Kaptein, Monique E. van Leerdam, John B. A. G. Haanen, Emile E. Voest, Noel F. C. C. de Miranda, Ton N. Schumacher, Lodewyk F. A. Wessels, Myriam Chalabi
Read the full article on Nature.
You can also read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
ESMO 2025 Day 3 Highlights Not to Miss
ESMO 2025 Day 4 Highlights Not to Miss
